Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Benef Microbes ; 10(8): 901-912, 2019 Dec 09.
Article in English | MEDLINE | ID: mdl-31965836

ABSTRACT

Type 1 diabetes mellitus (T1DM) is a disorder resulting from chronic autoimmune destruction of insulin-producing pancreatic ß-cells, lack of insulin production and hyperglycaemia. The aim of this study was to evaluate the hypothesis that streptozotocin-diabetic mice treated with Saccharomyces boulardii THT 500101 strain present improvement of glucose and triglycerides metabolism, reduction of liver inflammation concomitant with a beneficial impact in the gut microbiota profile. C57BL/6 male mice were randomly assigned into three groups: Control, Diabetes, Diabetes+Probiotic, and were euthanised 8 weeks after probiotic chronic administration. Mice submitted to treatment presented reduced glycemia in comparison with the diabetic group, which was correlated with an increase in C-peptide level and in hepatic glycogen content. Fat metabolism was significantly altered in streptozotocin-induced diabetic group, and S. boulardii treatment regulated it, leading to a decrease in serum triglycerides secretion, increase in hepatic triglycerides storage and modulation of inflammatory profile. The phenotypic changes seen from chronic S. boulardii treatment were found to be broadly associated with the changes in microbioma of diabetic animals, with increased proportion in Bacteroidetes, Firmicutes and Deferribacteres, and a decreased proportion of Proteobacteria and Verrucomicrobia phylum. Thus, the data presented here show up a novel potential therapeutic role of S. boulardii for the treatment and attenuation of diabetes-induced complications.


Subject(s)
Diabetes Complications/prevention & control , Diabetes Mellitus, Experimental/chemically induced , Gastrointestinal Microbiome/drug effects , Probiotics/pharmacology , Probiotics/therapeutic use , Saccharomyces boulardii/physiology , Streptozocin/toxicity , Animals , Bacteria/classification , Bacteria/drug effects , Bacteria/isolation & purification , Blood Glucose/drug effects , Diabetes Complications/metabolism , Diabetes Complications/pathology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Dyslipidemias/prevention & control , Hyperglycemia/prevention & control , Inflammation , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Probiotics/administration & dosage , Triglycerides/metabolism
2.
Dig Liver Dis ; 40(6): 460-7, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18096448

ABSTRACT

BACKGROUND: Except for injecting drug use, other routes of transmission for hepatitis C virus among HIV-AIDS patients have not been consistently described, and risk estimates are often not adjusted for confounding factors. AIMS: To evaluate characteristics associated with hepatitis C virus infection in individuals infected with the HIV. PATIENTS: Cases were patients co-infected by HIV and hepatitis C virus, and controls were infected only by HIV. METHODS: Cases and controls were consecutively enrolled at a public health care outpatient HIV-AIDS reference centre in Porto Alegre, Southern Brazil. RESULTS: A total of 227 cases (63% men; 40.3+/-8.7 years) and 370 controls (44.6% men; 38.9+/-9.8 years) were enrolled in the study. In a multiple logistic regression model, male gender (odds ratio 1.9; 95% confidence interval 1.3-2.7), age between 30 and 49 years (odds ratio 2.1; 95% confidence interval 1.2-3.7), elementary school education (odds ratio 4.2; 95% confidence interval 1.9-9.6), lower family income (odds ratio 1.7; 95% confidence interval 1.1-2.7), sharing personal hygiene objects (odds ratio 2.0; 95% confidence interval 1.3-3.3), using injected drugs (odds ratio 21.6; 95% confidence interval 10.8-43.0) and crack cocaine (odds ratio 2.8; 95% confidence interval 1.1-6.9) were independently associated with co-infection by hepatitis C virus. CONCLUSION: These results confirm the risk profile for hepatitis C virus-HIV infection and suggest that sharing personal hygiene objects might explain the transmission of virus C to those not infected by the usual routes, which may be of relevance for developing preventive strategies.


Subject(s)
HIV Infections/complications , Hepatitis C/complications , Hepatitis C/prevention & control , Adult , Brazil/epidemiology , Case-Control Studies , Female , HIV Infections/epidemiology , Hepatitis C/epidemiology , Hepatitis C/transmission , Humans , Male , Middle Aged , Risk Assessment , Risk Factors
3.
Transplant Proc ; 38(6): 1922-3, 2006.
Article in English | MEDLINE | ID: mdl-16908324

ABSTRACT

UNLABELLED: Our objective was to investigate the potential risk factors associated with cytomegalovirus (CMV) infection. PATIENTS AND METHODS: From January 1999 to December 2001, 163 liver transplantations were performed in 154 patients. The study inclusion criteria were absence of retransplantation and survival of more than 6 months. One hundred fifteen patients met the inclusion criteria. We determined variables such as age, gender, and number of hemecomponents as well as serum IgG CMV status of donors and recipients. We recorded the immunosuppression used by each patient. CMV infection was detected by positive antigenemia. RESULTS: Recipient mean age was 50 years. The etiology of cirrhosis was viral (n = 57; 49.6%), alcoholic (n = 20; 17.4%), virus and alcohol (n = 15; 13.0%), cryptogenic (n = 14; 12.2%), or other causes (n = 9; 7.8%). CMV infection was positive in 75 patients (65.8%). There was no relation between infection and age, gender, or CMV IgG donor recipient status, or the number of hemecomponent units. The risk was 3.8-fold higher for patients receiving a three-drug compared with a two-drug regimen. When cyclosporine was used instead of tacrolimus, the risk of CMV infection was 4.3-fold higher. Logistic regression analysis revealed cyclosporine (OD=5.8) and a three-drug regimen (OD=6.7) to have stronger associations with CMV infection. CONCLUSION: The use of cyclosporine (OD=5.8) and a three-drug regimen (OD=6.7) are risk factors for CMV infection.


Subject(s)
Cytomegalovirus Infections/epidemiology , Liver Transplantation/adverse effects , Postoperative Complications/virology , Cyclosporine/adverse effects , Cyclosporine/therapeutic use , Cytomegalovirus/isolation & purification , Female , Humans , Immunoglobulin G/blood , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Retrospective Studies , Risk Factors
4.
Transplant Proc ; 38(6): 1924-5, 2006.
Article in English | MEDLINE | ID: mdl-16908325

ABSTRACT

UNLABELLED: Cytomegalovirus (CMV) is one of the most common and serious opportunistic infections in solid organ transplant patients. In different series the incidence of CMV infection ranges from 25% to 85%. An indirect effect of infection includes reduced long-term patient and allograft survival. Our objective was to determine the relationship between CMV infection and patient survival after orthotopic liver transplantation. PATIENTS AND METHODS: From January 1999 to December 2001, 163 orthotopic liver transplantations were performed in 154 patients. The inclusion criteria for this analysis were the absence of retransplantation and survival of more than 6 months. One hundred fifteen patients met the inclusion criteria. CMV infection was detected by positive antigenemia. RESULTS: CMV infection occurred in 65.8% of patients after orthotopic liver transplantation. Their 5-year survival was 85%, with no difference observed between patients with or without infection (P = .8). CONCLUSION: CMV infection did not interfere with patient survival after orthotopic liver transplantation.


Subject(s)
Cytomegalovirus Infections/epidemiology , Liver Transplantation/physiology , Postoperative Complications/virology , Cytomegalovirus Infections/mortality , Cytomegalovirus Infections/physiopathology , Humans , Liver Transplantation/mortality , Patient Selection , Postoperative Complications/mortality , Retrospective Studies , Survival Analysis , Survivors
5.
Transplant Proc ; 36(4): 843-5, 2004 May.
Article in English | MEDLINE | ID: mdl-15194289

ABSTRACT

BACKGROUND: The mechanisms underlying liver graft dysfunction are not completely defined, although much of the injury derives from oxidative stress in organ reperfusion. The antioxidant glutathione in its reduced form (GSH) is an important agent to detoxify oxygen species after reperfusion. However, this effect might be limited by low concentrations at the end of cold storage. The objective of this study was to evaluate GSH and glutathione oxidized (GSSG) hepatic levels pre- and postreperfusion and correlate with hepatocellular injury and liver function in the 5 subsequent days after transplantation. METHODS: Liver biopsies were taken immediately before implant and 2 hours after venous reperfusion in 34 grafts, determining GSH, GSSG levels, and GSSG/GSH ratio. Aminotransferases (ALT, AST) and PT were measured for 5 days. RESULTS: There was a strong decrease in GSH concentration (P <.0001), increase of GSSG levels (P <.01), and increase of the GSSG/GSH ratio (P <.0001). No correlations were found between GSH, GSSG, or GSH/GSSH levels and AST, ALT, and PT. CONCLUSION: Glutathione levels showed significant changes after 2 hours of reperfusion, due to intense oxidative stress. Therapies to replenish GSH should be considered as a protective measure to avoid liver graft dysfunction after transplantation.


Subject(s)
Hepatocytes/cytology , Liver Transplantation/physiology , Oxidative Stress/physiology , Adenosine , Adult , Allopurinol , Cause of Death , Female , Glutathione/metabolism , Glutathione Disulfide/metabolism , Humans , Insulin , Liver , Liver Function Tests , Liver Transplantation/mortality , Male , Organ Preservation/methods , Organ Preservation Solutions , Raffinose , Reperfusion Injury , Retrospective Studies
6.
Transplant Proc ; 36(4): 961-3, 2004 May.
Article in English | MEDLINE | ID: mdl-15194334

ABSTRACT

The aim of the study was to investigate risk factors associated with cytomegalovirus (CMV)-positive antigenemia in orthotopic liver transplant (OLT) patients. Sixty-nine patients undergoing OLT during 2001 were retrospectively evaluated for CMV antigenemia during a follow-up of 6 months after transplantation for demographic variables, pretransplant donor and recipient CMV serologic status, etiology of liver disease, number of blood transfusions, and type of immunosuppression. Among the 69 patients who underwent 71 OLT in this period, 43 met study criteria. Mean age was 49.7 +/- 10.8 years and 60.5% were men. End-stage liver disease was the indication for liver transplant, except in one case. The most prevalent etiology of liver disease was hepatitis C and/or alcohol in 66% of the cases. CMV-positive status was recorded in 74% of donors and 95% of recipients. None of the CMV-negative recipients received a positive donor allograft. CMV-positive antigenemia was 84% with 12% having two episodes of infection. There was no correlation between CMV infection and age, gender, etiology of liver disease, or number of blood transfusions. However, all patients using cyclosporine had CMV-positive antigenemia compared with 61% using tacrolimus (P <.032). In this study, the incidence of CMV infection after OLT in adult patients was slightly higher than reported in literature. No risk factor was associated with CMV antigenemia; however, this study suggests a higher probability of CMV infection among patients treated with cyclosporine.


Subject(s)
Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/immunology , Liver Transplantation , Postoperative Complications/virology , Antigens, Viral/blood , Female , Follow-Up Studies , Humans , Liver Diseases/classification , Liver Diseases/etiology , Liver Diseases/surgery , Male , Middle Aged , Risk Factors , Time Factors
7.
Rev Panam Salud Publica ; 9(3): 161-8, 2001 Mar.
Article in Portuguese | MEDLINE | ID: mdl-11349351

ABSTRACT

The objective of this study was to review the literature concerning laboratory tests to detect hepatitis C virus infection, which have been available since 1989. The diagnosis of hepatitis C is mainly based on serological techniques and on molecular techniques. Serological techniques to detect hepatitis C virus antibodies are the method of choice to identify past or present infection. There are two types of serological assays: highly sensitive enzyme-linked immunosorbent screening assays; and more specific immunoblot techniques, which are used as supplemental or confirmatory tests. With respect to molecular diagnostic techniques, there are several types of assays. One such assay detects viral RNA. It is useful for diagnosis in such situations as the early stages of infection, with immunosuppressed patients, and with persons who have a low probability of infection. Molecular assays are also recommended before treatment with interferon and ribavirin, in order to monitor response to treatment. Other assays allow determination of viral load by either target amplification (as in polymerase chain reaction) or signal amplification (as in branched-DNA). Determining the hepatitis C virus genotype is possible using either molecular techniques or serotyping. Determining viral load and genotype is useful for planning the duration of interferon and ribavirin treatment. There have been major advances in the diagnosis of hepatitis C in the past decade Improvements in the sensitivity and specificity of antibody tests have provided faster, less expensive diagnoses. However, more accurate assays are still needed for such groups as immunosuppressed persons and acute hepatitis patients.


Subject(s)
Hepatitis C/diagnosis , Enzyme-Linked Immunosorbent Assay , Hepacivirus/genetics , Hepacivirus/immunology , Hepatitis C/immunology , Hepatitis C Antibodies/analysis , Humans , Immunoblotting , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Viral Load
8.
Arq Neuropsiquiatr ; 58(2A): 304-9, 2000 Jun.
Article in Portuguese | MEDLINE | ID: mdl-10849632

ABSTRACT

Neurologic complications are important source of morbi-mortality, in liver transplantation. They result from previous factors, alterations during the surgical procedure, effects from immunosuppressor drugs, coagulopathy and infections. We analyzed, retrospectively, the chronology, causes, and frequencies of neurologic alterations in thirty adult patients submitted to liver transplantation, and our results differ slightly from those registered in other series.


Subject(s)
Liver Transplantation/adverse effects , Nervous System Diseases/etiology , Adult , Female , Humans , Liver Diseases/surgery , Male , Middle Aged , Retrospective Studies , Sex Factors , Statistics, Nonparametric
12.
Rev Inst Med Trop Sao Paulo ; 38(5): 323-7, 1996.
Article in English | MEDLINE | ID: mdl-9293073

ABSTRACT

From March 1994 to November 1995 24 cases of human parvovirus B19 infection were seen at the Infectious Diseases Department of the Hospital Universitário Antônio Pedro, Niterói-RJ. Serum samples for IgM detection (capture enzyme immunoassay) were positive from the 1st to the 27th day after the onset of the exathema. The classical features of erythema infectiosum (slapped cheecked syndrome) were observed in 8 (33.3%) cases all of them children. Eight patients (6 adults and 2 children) presented a symmetrical polyartropathy, seen more frequently in women. These results show that B19 infection diagnosis is difficult when the disease does not present the classical features and because of the frequent involvement of the joints this infection should be considered in the differential diagnosis of early rheumatoid arthritis.


Subject(s)
Arthritis, Infectious/diagnosis , Arthritis, Juvenile/diagnosis , Erythema Infectiosum/diagnosis , Adolescent , Adult , Arthritis, Infectious/epidemiology , Arthritis, Infectious/microbiology , Arthritis, Juvenile/epidemiology , Arthritis, Juvenile/microbiology , Child , Child, Preschool , Diagnosis, Differential , Erythema Infectiosum/epidemiology , Erythema Infectiosum/etiology , Female , Humans , Infant , Male , Prospective Studies
13.
GED gastroenterol. endosc. dig ; 11(4): 163-8, out.-dez. 1992.
Article in Portuguese | LILACS | ID: lil-197657

ABSTRACT

O virus da hepatite B é de distribuiçäo universal. Calcula-se que 300 milhöes de indivíduos, em escala mundial, estao cronicamente contaminados pelo mesmo. A transmissäo mae-filho do vírus da hepatite B, que ocorre durante o parto, a chamada transmissäo perinatal, representa fonte muito importante de disseminaçao da infecçäo, principalmente naquelas regiöes em que é alta a endemicidade do HVB. Também é bem sabido que quanto mais precoce for a contaminaçäo com o vírus B, maiores seräo as chances de cronificaçäo do processo. Conseqüentemente, a identificaçäo de mäes AgHBs positivas e administraçäo de HBIG e vacina aos seus recém-nascidos säo altamente recomendadas.


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Infant , Hepatitis B/transmission , Infectious Disease Transmission, Vertical , Hepatitis B Vaccines , Hepatitis B/epidemiology , Prevalence
14.
J Pediatr Surg ; 27(9): 1229-30, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1432537

ABSTRACT

The granulomatous peritonitis by ascaris (GPA) is a rare complication of intestinal ascariasis due to the perforation of the digestive tract by the adult worm, which deposits its ova in free peritoneum; therefore, provoking an intense granulomatous inflammatory reaction. We report a case of an 8-year-old boy with GPA, emphasizing the clinical and diagnostical aspects and the therapeutics procedures.


Subject(s)
Ascariasis/complications , Ascaris lumbricoides , Granuloma/parasitology , Peritonitis/parasitology , Animals , Ascariasis/pathology , Ascaris lumbricoides/isolation & purification , Child , Granuloma/pathology , Humans , Male , Peritonitis/pathology
15.
Arq Gastroenterol ; 25(1): 29-32, 1988.
Article in Portuguese | MEDLINE | ID: mdl-3066305

ABSTRACT

The authors describe by the first time in the literature a patient with congenital hepatic fibrosis and Caroli's disease complicated by spontaneous bacterial peritonitis. The possible routes of ascitic infection are discussed.


Subject(s)
Biliary Dyskinesia/complications , Escherichia coli Infections , Gallbladder Diseases/complications , Liver Cirrhosis/congenital , Peritonitis/etiology , Adolescent , Ascitic Fluid/analysis , Female , Humans , Liver Cirrhosis/complications , Peritonitis/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...